Search results
Earnings call: Compugen outlines progress and plans in Q1 2024 earnings By Investing.com
Investing.com· 3 hours agoThe company highlighted its successful transition of AI-predicted drug targets to clinical trials...
BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why
Zacks via Yahoo Finance· 8 hours agoBeigene's (BGNE) shares surge 32% in a month due to the label expansion of one of its key oncology...
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga via Yahoo Finance· 4 days agoProteologix’s portfolio includes: PX128, a bispecific antibody targeting IL-13 plus TSLP, which is...
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Finance· 5 days agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 7 days agoThe session, being offered today, Tuesday May 14, 2023 at 8:30 AM Eastern time and entitled " Development of ...
AstraZeneca Plans $1.5 Billion Manufacturing Facility In Singapore
The Wall Street Journal· 18 hours agoThe Anglo-Swedish pharmaceutical giant plans to build a $1.5 billion manufacturing facility in...
From infection to chronic illness: Learning from long COVID
Medical Xpress· 8 hours agoWhile there are known links between bacterial and viral infections with post-acute infection syndromes, much is still unknown about the mechanisms that underpin these illnesses or why they occur ...
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga· 4 days agoThursday, Johnson & Johnson JNJ agreed to acquire Proteologix Inc., a privately held biotechnology...
AstraZeneca's COVID prevention drug cuts risk of disease in vulnerable patients
Reuters via AOL· 5 days agoThe long-acting antibody therapy called sipavibart showed a "statistically significant reduction" in...
Johnson & Johnson to acquire Proteologix for $850 million By Reuters
Investing.com· 5 days agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...